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Abstract
Background: Salmonella enterica serovar Typhi is transmitted by fecally contaminated food and water and causes
approximately 22 million typhoid fever infections worldwide each year. Most cases occur in developing countries, where
approximately 4% of patients develop intestinal perforation (IP). In Kasese District, Uganda, a typhoid fever outbreak
notable for a high IP rate began in 2008. We report that this outbreak continued through 2011, when it spread to the
neighboring district of Bundibugyo.
Methodology/Principal Findings: A suspected typhoid fever case was defined as IP or symptoms of fever, abdominal pain,
and $1 of the following: gastrointestinal disruptions, body weakness, joint pain, headache, clinically suspected IP, or non-
responsiveness to antimalarial medications. Cases were identified retrospectively via medical record reviews and
prospectively through laboratory-enhanced case finding. Among Kasese residents, 709 cases were identified from August 1,
2009–December 31, 2011; of these, 149 were identified during the prospective period beginning November 1, 2011. Among
Bundibugyo residents, 333 cases were identified from January 1–December 31, 2011, including 128 cases identified during
the prospective period beginning October 28, 2011. IP was reported for 507 (82%) and 59 (20%) of Kasese and Bundibugyo
cases, respectively. Blood and stool cultures performed for 154 patients during the prospective period yielded isolates from
24 (16%) patients. Three pulsed-field gel electrophoresis pattern combinations, including one observed in a Kasese isolate in
2009, were shared among Kasese and Bundibugyo isolates. Antimicrobial susceptibility was assessed for 18 isolates; among
these 15 (83%) were multidrug-resistant (MDR), compared to 5% of 2009 isolates.
Conclusions/Significance: Molecular and epidemiological evidence suggest that during a prolonged outbreak, typhoid
spread from Kasese to Bundibugyo. MDR strains became prevalent. Lasting interventions, such as typhoid vaccination and
improvements in drinking water infrastructure, should be considered to minimize the risk of prolonged outbreaks in the
future.
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Introduction
Salmonella enterica serovar Typhi (Salmonella Typhi) is the Gram-
negative bacillus that causes typhoid fever, a systemic infection
transmitted through food and water contaminated with
human feces. Typhoid fever is characterized by numerous non-
specific symptoms, including high fever, headache, malaise,
joint pain, abdominal pain, and gastrointestinal symptoms such
as nausea, vomiting, constipation, and diarrhea. The case fatality
rate is less than 1% with prompt and effective antimicrobial
treatment, but may reach 41% in developing countries where
access to care is limited [1]. The most serious complication,
intestinal perforation, occurs in approximately 3.8% of patients in
the developing world; in these areas, reported rates of intestinal
perforation range from 0.1–39% [2]. Intestinal perforation has
been associated with male gender, older age, delayed or
inappropriate antimicrobial therapy, and short duration of
symptoms [1,3,4].
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Typhoid is endemic in many countries with poor sanitation and
hygiene and limited access to safe water. Although well-studied in
South and Southeast Asia, where it is widely endemic, typhoid
fever has only recently been recognized as a significant contributor
to the burden of febrile illness in sub-Saharan Africa. Since 2008,
severe typhoid fever outbreaks have been reported in rural Malawi
[5] and Uganda [6], and in the capital cities of Zimbabwe [7] and
Zambia [8]. Typhoid was recently shown to be highly endemic in
an urban population in Kenya; the typhoid incidence of 247 cases
per 100,000 persons in this area was similar to that found in highly
endemic areas in Southeast Asia [9]. Typhoid diagnosis in malaria
endemic areas of sub-Saharan Africa is challenged by the similar
clinical presentations of typhoid and malaria and the limited
availability of laboratory resources in many countries. Blood
culture is time and resource intensive, and rapid diagnostic tests,
such as TUBEX-TF, are useful for preliminary assessment of
potential outbreaks but do not have adequate sensitivity and
specificity for diagnosis of individual patients [10–12]. Limited
data from Africa suggests that antimicrobial resistance is increasing
among Salmonella Typhi isolates, including a rise in the prevalence
of multidrug resistance (MDR), defined as resistance to the three
traditional first-line antimicrobials, ampicillin, chloramphenicol,
and trimethoprim-sulfamethoxazole [13], and emergence of
decreased susceptibility to ciprofloxacin [5,9,14].
Kasese and Bundibugyo are neighboring rural agricultural
districts in western Uganda that border the Democratic Republic
of the Congo (Figure 1). Epidemics of waterborne and foodborne
diarrheal diseases, such as cholera [15] and typhoid fever [6], have
historically plagued both districts. Malaria is endemic. Water
treatment is largely an individual responsibility, as coverage with
improved water sources is low, and neither district has municipal
water systems that deliver chlorinated water. An outbreak of
typhoid fever with a high rate of intestinal perforation began in
2008 in Kasese district [6]. Among 21 Salmonella Typhi isolates
obtained through surveillance conducted from March 4 to July 31,
2009, only 1 (5%) was multidrug-resistant and no resistance to
nalidixic acid or ciprofloxacin was detected [6].
We report the continuation of the outbreak in Kasese district,
present evidence for its extension into Bundibugyo, a neighboring
district, and describe a dramatic increase in the prevalence and
extent of antimicrobial resistance since 2009. In August 2011, an
outbreak of undiagnosed febrile illness, which we later confirmed
as typhoid fever, began in the neighboring district of Bundibugyo,
and a high number of patients with intestinal perforation were
noted in Kasese. In response to a request to investigate from the
Uganda Ministry of Health and in collaboration with the Uganda
Ministry of Health and Kasese and Bundibugyo District Health
Offices, we implemented laboratory-enhanced prospective case
finding, conducted retrospective case finding for typhoid fever via
medical record reviews, and tested drinking water sources in both
districts to determine the scope and likely vehicles of the outbreaks.




A suspected case of typhoid fever was defined as surgically
diagnosed intestinal perforation consistent with Salmonella Typhi
infection or illness characterized by fever and abdominal pain for
$1 day and at least one of the following signs or symptoms —
gastrointestinal disruptions, such as vomiting, diarrhea, or
constipation, general body weakness, joint pain, headache, clinical
suspicion for intestinal perforation, or failure to respond to
antimalarial medications — with onset from January 1 to
December 31, 2011 in Bundibugyo residents and from August 1,
2009 to December 31, 2011 in residents of other districts,
including Kasese.
Case finding
The source populations for identifying cases of typhoid fever in
Kasese and Bundibugyo districts were persons seeking care at
government-affiliated and private not-for-profit health facilities in
these districts and at Fort Portal Regional Referral Hospital in
Kabarole district, which borders Kasese and Bundibugyo districts.
Cases of surgically-diagnosed intestinal perforation were identified
retrospectively from operating room logbooks and chart abstrac-
tions of intestinal perforation patients at Kilembe Mines Hospital,
Kagando Hospital, Bwera Hospital, St. Paul’s Health Center IV,
Bundibugyo Hospital, and Fort Portal Regional Referral Hospital.
Additional cases were identified retrospectively through linelists of
patients with surgically-diagnosed intestinal perforation main-
tained by Kasese hospitals, and linelists of suspected typhoid fever
cases maintained since August 2011 by the District Health Office
in Bundibugyo. Beginning in October 2011, typhoid cases were
identified prospectively through patient and caregiver interviews in
health care facilities and highly affected communities, and through
laboratory-enhanced case finding.
Laboratory-enhanced prospective case finding
Systematic, laboratory-enhanced prospective case finding was
conducted in Kasese from November 1 to December 31, 2011 and
in Bundibugyo from October 28 to December 31, 2011. Eighty-
two health facilities in Kasese and 21 in Bundibugyo were
provided with case report forms eliciting information about clinical
history, potential risk factors, and socioeconomic status. Health
facilities with the capacity to collect specimens in Kasese (15) and
Bundibugyo (3) were asked to collect blood and stool from all
patients with suspected intestinal perforation and from the first two
(Kasese) or three (Bundibugyo) patients who presented at the
facility and met the case definition each day.
Author Summary
Typhoid fever is an acute febrile illness caused by the
bacteria Salmonella Typhi and transmitted through food
and water contaminated with the feces of typhoid fever
patients or carriers. We investigated typhoid fever
outbreaks in two neighboring Ugandan districts, Kasese
and Bundibugyo, where typhoid fever outbreaks began in
2008 and 2011, respectively. In Kasese from August 2009–
December 2011, we documented 709 cases of typhoid
fever. In Bundibugyo from January–December 2011, we
documented 333 cases. Salmonella Typhi from Bundibu-
gyo and Kasese had indistinguishable molecular finger-
prints; laboratory and epidemiological evidence indicate
that the outbreak spread from Kasese to Bundibugyo.
Salmonella Typhi isolated during our investigation were
resistant to more antibiotics than isolates obtained from
Kasese in 2009. Drinking water in both districts was fecally
contaminated and the likely vehicle for the outbreaks. Our
investigation highlights that in unchecked typhoid fever
outbreaks, illness can become geographically dispersed
and outbreak strains can become increasingly resistant to
antibiotics. Lasting interventions, including investments in
drinking water infrastructure and typhoid vaccination, are
needed to control these outbreaks and prevent future
outbreaks.
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Laboratory testing
Blood, serum, and stool were collected according to the above
criteria at each facility daily from October 28 to December 31,
2011; prior to this, from October 18 to October 28, 2011,
specimens were collected from a sample of clinically-suspected
typhoid patients. Supplies for specimen collection and testing were
provided by the US Centers for Disease Control and Prevention
(CDC). CDC, the Kenya Medical Research Institute (KEMRI),
and the Uganda Central Public Health Laboratory (CPHL)
trained local laboratory technicians in microbiologic and serologic
techniques for typhoid fever diagnosis at one hospital and one
upper level health facility in Kasese and at one hospital in
Bundibugyo.
Blood (persons 10 years of age and older: 10 ml; children ,10
years: 1 ml of blood per year of age) was collected using standard
methods. Eight ml of blood (patients $10 years) or one-half the
sample volume (children ,10 years) were inoculated into an
Oxoid signal blood culture bottle; the remaining blood was placed
in a serum separator tube. Stool was collected according to
standard guidelines and inoculated into Cary-Blair transport
medium [16]. All samples were held at ambient temperature and
transported to district referral laboratories within 72 hours of
collection. Blood and stool cultures were performed per standard
protocols for isolation of Salmonella Typhi [17,18]. Isolates that
were biochemically or serologically typical of Salmonella Typhi
were forwarded to CPHL for confirmation and to CDC-Atlanta
for further characterization, including serotyping, pulsed-field gel
electrophoresis (PFGE), and antimicrobial susceptibility testing
(AST). PFGE, which is the current gold standard subtyping
technique for Salmonella, was conducted per standard protocols
[19] and PFGE patterns were analyzed using BioNumerics
software version 5.01 (Applied Maths, Inc., Austin, TX, USA).
AST was performed using disk diffusion [20] and broth
microdilution (Sensititre; Trek Diagnostics) according to the
manufacturer’s instructions. Where applicable, Clinical and
Laboratory Standards Institute (CLSI) 2012 interpretive criteria
were used to categorize antimicrobial susceptibility results [20].
For drugs that lack CLSI interpretive criteria, results were
classified using interpretive criteria from the CDC National
Antimicrobial Resistance Monitoring System [21]. Serological
testing was performed with TUBEX- TF (IDL Biotech) per
product insert.
Environmental sampling
Water samples collected from drinking water sources in Kasese
and Bundibugyo were tested for the presence of total coliforms and
Escherichia coli in 100 ml, 1 ml, or 100 ml of water using the
Colilert-18 test kit (IDEXX, Westbrook, ME). One-ml samples
and 100-ml samples were diluted in 100 ml of sterile, distilled water
before addition of the Colilert reagent. In Kasese, two surface
water sources and six drinking water taps were sampled. In
Bundibugyo, river water upstream of a gravity flow scheme (GFS)
Figure 1. Map of Uganda showing affected districts.
doi:10.1371/journal.pntd.0002726.g001
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intake, the GFS outflow tank, two GFS taps, and one tap from a
town municipal water supply were sampled.
Data analysis
Data were entered into electronic databases and analyzed using
SAS 9.3 (SAS Institute, Cary, NC). Statistical testing was done
using the Fisher’s exact test for categorical data and the Wilcoxon
rank-sum test for continuous data. For analysis of prospectively-
identified cases, non-yes responses for symptoms, animal owner-
ship, and assets were structurally missing on most forms and were
imputed as negative responses. P values,0.05 were considered
significant.
Ethics statement
The primary purpose of this activity was to identify, character-
ize, and control disease in response to an immediate public health
threat. As such, the human subjects research designee in the
Division of Foodborne, Waterborne, and Environmental Diseases
at CDC determined that the activities constituted public health
response rather than research. Patients with suspected typhoid
fever were offered diagnostic testing through routine culture of
stool and blood specimens and through serologic testing as part of
standard clinical care, and informed consent specifically for this
testing was not obtained.
Results
Case finding
During the period August 1, 2009 to January 6, 2012, 1,341
suspected typhoid fever cases were identified, including 1,049
(78%) identified retrospectively and 292 (22%) identified prospec-
tively. Among 1,165 patients for whom district of residence was
reported, 709 (61%) resided in Kasese, 333 (29%) resided in
Bundibugyo, and 83 (7%) resided in Kabarole district. Thirty-
seven were from other districts and three were residents of the
Democratic Republic of Congo. Among Kasese patients, more
cases with intestinal perforation were recorded in 2011 compared
to previous years (Figure 2A); during the period of laboratory-
enhanced case-finding (November to December 2011), cases with
intestinal perforation represented a small fraction of all cases
identified. In Bundibugyo, a sharp increase in cases of typhoid
fever with and without intestinal perforation was observed
beginning in August 2011 (Figure 2B); the outbreak was reported
to the Uganda Ministry of Health later that month.
Intestinal perforation status was recorded or imputed for 697
(98%) of 709 Kasese patients and 293 (88%) of 333 Bundibugyo
patients; the frequency of intestinal perforation was 82% and 20%,
respectively (Table 1). In Kasese, but not Bundibugyo, all sources
of retrospective case finding recorded only patients with intestinal
perforation instead of all patients with suspected typhoid. Males
were disproportionately affected by intestinal perforation in both
districts, accounting for 59% and 66% of Kasese and Bundibugyo
patients with intestinal perforation, and only 46% and 40% of
patients without intestinal perforation, respectively. The median
age of Bundibugyo patients was 13 years (range: ,1–68 years).
Among Bundibugyo patients with intestinal perforation, the
median age of males, 15 years, was older than that of females,
who had a median age of 10 years (P = 0.03). Female patients with
intestinal perforation were younger than females without intestinal
perforation, who had a median age of 18 years (P = 0.008). Among
Bundibugyo patients, the proportion with intestinal perforation
was significantly higher for males than females for patients aged
20–29 years (40% vs. 0%, P = 0.0006) and 30–39 years (42% vs.
0%, P = 0.03) (Figure 3). Similar associations between age,
gender and intestinal perforation status were also identified in
Kasese patients.
Kasese patients resided in all 21 sub-counties in the district.
During the 29-month case finding period, there were 98 cases of
clinically-diagnosed typhoid fever per 100,000 persons district-
wide; in 2011 alone, there were 58 cases per 100,000 persons. The
Bukonzo West health subdistrict, comprising the western sub-
counties of Bwera, Ihandiro, Isango, Karambi, and Mpondwe-
Lhubiriha Town Council, had the highest typhoid incidence from
August 2009 to December 2011, 115 cases per 100,000 persons.
The incidence of typhoid fever was 139 per 100,000 in
Bundibugyo District for the period January 1, 2011 to December
31, 2011. During this period, four neighboring Bundibugyo sub-
counties had an incidence of typhoid fever greater than 100 cases
per 100,000 persons: Kirumya (990 per 100,000), Bubukwanga
(234 per 100,000), Bukonzo (199 per 100,000), and Bundibugyo
Town Council (155 per 100,000).
Laboratory-enhanced case finding
Case report forms for 149 Kasese residents, 128 Bundibugyo
residents, and 13 residents of other districts or for whom district of
residence could not be determined were completed at health
facilities from October 11, 2011 to January 6, 2012. The most
common symptoms of the 277 case-patients from Kasese and
Bundibugyo, other than fever and abdominal pain (both required
by the case definition), were weakness (84%), headache (82%), and
joint pain (71%) (Table 2). Six percent of patients had intestinal
perforation. Before the visit where the case report form was
completed, patients reported feeling ill for a median of 7 days
(range 1–240 days, n = 267), including having fever for a median
of 6 days (range 1–240 days, n = 268), and abdominal pain for a
median of 4 days (range 1–730 days, n = 262).
Seventy percent of respondents reported seeking care for their
illness before the health care visit during which the case report
form was completed (Table 3). Patients most frequently sought
care at a drug shop or pharmacy (49%) or a health center or
hospital (48%); a small fraction consulted an herbalist (7%) or
traditional healer (1%). Antibiotics were taken by 45% of patients.
Metronidazole, which is not effective against Salmonella Typhi, was
the antimicrobial most frequently reported and was used by 36%
of patients who reported taking antimicrobials. Ciprofloxacin, co-
trimoxazole, and amoxicillin were taken by 27%, 26%, and 24%
of patients who reported taking antimicrobials, respectively; only
5% reported taking chloramphenicol. Nearly one-quarter (23%) of
patients who reported taking antimicrobials had taken $2 agents
to treat the same illness episode.
In Kasese, tap water was the most commonly reported primary
source of drinking water during the month before illness onset and
was reported by 84 (62%) of 136 patients. Other primary drinking
water sources were stream or river water, spring water, and wells,
used by 22 (16%), 14 (10%), and 2 (1%) patients, respectively. In
Bundibugyo, tap water was also the most common primary source
of drinking water and was reported by 56 (46%) of 122 patients.
Forty-three (35%) patients used stream or river water, 11 (9%)
used spring water, 5 (4%) used well water, and 2 (2%) used bottled
water. Among the 50 Bundibugyo patients who reported tap water
as their primary drinking water source and also reported their sub-
county of residence, 24 (48%) resided in subcounties where tap
water was provided by a single GFS, the Kirumya-Bubukwanga
GFS, and 8 (16%) resided in Bundibugyo Town Council, the
district’s largest town. Among the 35 Bundibugyo patients who
used river water as their primary drinking water source and
reported the name of the river they used, 15 (43%) used the
Kirumya River, which is the source of the Kirumya-Bubukwanga
Prolonged Typhoid Fever Outbreak – Uganda
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GFS. Clustering by drinking water source was not observed
among Kasese patients.
Among 208 patients, 30 (14%) reported treating their water in
the month before they became ill. Among those who treated their
water, 20 (67%) boiled water, 7 (23%) used a chlorine product, 1
(3%) used PuR, a chlorination-flocculation product, and 2 (0.7%)
used a treatment method not listed.
Intestinal perforation risk factors
Significant differences were observed in the symptoms, clinical
histories, and socioeconomic status of the 18 patients with
confirmed or suspected intestinal perforation and the 250 patients
without intestinal perforation who were identified through
prospective laboratory-enhanced case-finding (Table 4). Patients
with intestinal perforation were more likely than those without
intestinal perforation to have sought health care for the same
illness episode before the visit when the enrollment form was
completed (100% vs. 69%, P = 0.004) and to report that care was
sought at a health center or hospital (88% vs. 46%, P = 0.0008).
Patients with intestinal perforation reported not responding to
antimalarials more frequently than patients without intestinal
perforation (71% vs. 31%, respectively; P = 0.003), although
reported antimalarial use did not differ by intestinal perforation
status. Patients with intestinal perforation were more likely than
those without intestinal perforation to report taking antibiotics (75%
vs. 44%, respectively, P = 0.02), and among patients who took
antibiotics, were more likely to report taking chloramphenicol (25%
vs. 1%, respectively; P = 0.003). Compared to patients without
intestinal perforation, more than twice the proportion of patients
with intestinal perforation reported taking $2 antibiotics to treat the
same illness episode (58% vs. 24%; P = 0.04). Patients with intestinal
perforation were less likely to own two or more listed household
items (radio, mobile telephone, foam mattress, bicycle, and
motorcycle) than patients without intestinal perforation (56% vs.
80%, respectively; P = 0.03); employment and number of animals
owned did not vary by intestinal perforation status.
Laboratory investigation
Salmonella Typhi was isolated from seven (9%) of 74 blood
cultures and one (2%) of 47 stool cultures from Kasese patients,
and from 15 (21%) of 72 blood cultures and one (10%) of 10 stool
cultures from Bundibugyo patients. In total, eight (11%) of 75
Kasese patients and 16 (20%) of 79 Bundibugyo patients tested
were culture-confirmed. Two (14%) of 14 patients with intestinal
perforation who had a blood culture performed had Salmonella
Typhi isolated.
Figure 2. Typhoid fever cases by month of illness onset and intestinal perforation status. (A) Kasese District, August 1, 2009–December
31, 2011, n = 695 with known or estimated onset date and known intestinal perforation status (B) Bundibugyo District, January 1–December 31, 2011,
n = 293 with known or estimated onset date and known intestinal perforation status.
doi:10.1371/journal.pntd.0002726.g002
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Salmonella Typhi isolates from five of the eight culture-confirmed
Kasese cases and 13 of the 16 culture-confirmed Bundibugyo cases
were further characterized at the U.S. Centers for Disease Control
and Prevention in Atlanta. PFGE subtyping revealed four distinct
XbaI/BlnI pattern combinations among the five Kasese isolates
and six distinct XbaI/BlnI pattern combinations among the 13
Bundibugyo isolates. When compared to the PulseNet Global
Salmonella Typhi database, a database of globally distributed Typhi
isolates, these pattern combinations were unique with the
exception of a single pattern combination, pattern combination
A, which was observed in the single chloramphenicol resistant
Kasese isolate from 2009 (Figure 4). Among the 2011 isolates,
pattern combination A was the pattern combination most
frequently observed and was shared by two Kasese isolates and
six Bundibugyo isolates, all of which were chloramphenicol
resistant. Two novel pattern combinations, designated B and C,
were also shared by isolates from both districts.
Eighteen isolates were tested for susceptibility to a panel of
antimicrobials that included amoxicillin/clavulanic acid, ampicillin,
ceftriaxone, chloramphenicol, ciprofloxacin, nalidixic acid, streptomy-
cin, sulfisoxazole, tetracycline, and trimethoprim-sulfamethoxazole.
Two isolates, both from Bundibugyo patients, were pan-susceptible.
Fifteen (83%) isolates were resistant to ampicillin, chloramphenicol,
and trimethoprim-sulfamethoxazole (MDR), and were also resistant
to sulfisoxazole, streptomycin, and tetracycline. A single isolate,
from Kasese, was resistant to nalidixic acid and showed interme-
diate susceptibility to ciprofloxacin; it was fully susceptible to other
antimicrobials tested.
TUBEX-TF serological testing was positive for 23 (35%) of 65
Kasese patients and 13 (45%) of 29 Bundibugyo patients. Among
the 59 patients who had both a blood culture and a TUBEX-TF
serological test performed, six (10%) had Salmonella Typhi isolated
from blood or stool and tested positive by TUBEX-TF, four (7%)
had a blood culture positive for Salmonella Typhi but a negative
TUBEX-TF test, 15 (25%) had blood culture negative for
Salmonella Typhi but had a positive TUBEX-TF test, and 34
(58%) were blood culture and TUBEX-TF negative. Thirteen
(7%) of 182 Kasese and Bundibugyo patients tested were positive
for malaria by RDT or blood smear; one (,1%) of 124 patients
with blood or stool culture and malaria diagnostic results reported
was positive for both typhoid and malaria.
Environmental sampling
Water samples were collected from six drinking water taps and
two surface water sources in Kasese and three drinking water taps
and one surface water source in Bundibugyo. Total coliforms were
present in all samples. E. coli were detected in 100 mL of water
from four (67%) of six Kasese drinking water taps (corresponding
to a concentration of $1 cfu/100 mL) and in 100 ml of water from
the rivers Rwimi and Hima (corresponding to a concentration of
$1000 cfu/100 mL). In Bundibugyo, E. coli were present in
100 ml of water from the Kirumya river upstream of the Kirumya-
Bubukwanga GFS intake, from the GFS outflow tank, and from
two taps on the GFS and one tap in the Bundibugyo Town
Council municipal water supply. E. coli were also present in 1 ml of
water from the two taps on the GFS (corresponding to a
concentration of $100 cfu/100 mL); the Bundibugyo Town
Council municipal water supply and Kasese tap water were not
tested at volumes below 100 mL.
Discussion
A large and severe typhoid fever outbreak in rural western
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neighboring district, and became more refractory to antimicrobial
treatment. In 2009, an investigation suggested that contaminated
drinking water was the most likely vehicle of infection, and general
prevention measures such as hand washing, improved sanitation,
and promotion of household water treatment were recommended
[6]. Absent a sustained and widespread intervention campaign, a
resurgence of cases with intestinal perforation was investigated in
2011. Molecular subtyping and epidemiologic evidence from the
2011 investigation indicate that the typhoid outbreak persisted in
Kasese and spread to the neighboring district of Bundibugyo.
Compared to Salmonella Typhi isolated from Kasese patients over a
six-week period in 2009, of which only one isolate (1/21; 5%) was
multidrug resistant [6], isolates obtained from Kasese and
Bundibugyo patients over the three-month period October to
December 2011 were more likely to be multidrug resistant.
Additionally, an isolate with reduced susceptibility to ciprofloxa-
cin, the current recommended first-line treatment for uncompli-
cated typhoid, was identified for the first time among outbreak
strains. Across the 2009 and 2011 enhanced case finding periods,
the frequency of co-trimoxazole and chloramphenicol use were
similar (29% vs. 26% and 9% vs. 5%, respectively), indicating that
changes in antibiotic use do not explain the increased frequency of
MDR isolates in 2011. These findings demonstrate that the
ramifications of severe, uncontrolled typhoid outbreaks include
outbreak strains that become increasingly resistant to lifesaving
antibiotics and the spread of disease to neighboring areas.
Selective recognition and documentation of patients with
intestinal perforation, the most severe complication of typhoid
fever, led to an underestimation of the magnitude of the outbreak
and an overestimation of the proportion of reported cases with
intestinal perforation. Although the overall proportion of cases
with intestinal perforation was 82% in Kasese and 20% in
Bundibugyo, prospective case finding in district health facilities
showed that patients with intestinal perforation represented only
8% of Kasese patients and 3% of Bundibugyo patients, or only 6%
of all typhoid cases. Inflation of the intestinal perforation rate as an
artifact of retrospective case finding methods was more pro-
nounced in Kasese, where linelists recorded only patients with
intestinal perforation, compared with Bundibugyo, where all
suspected typhoid cases were included on the linelist. Extrapolat-
ing from the 570 Kasese intestinal perforation cases identified from
August 1, 2009 to December 31, 2011 and the 8% intestinal
perforation rate observed through prospective case-finding, we
estimate that 7,125 cases of typhoid occurred among Kasese
residents during this period, giving an estimated annual incidence
of 409 cases per 100,000 persons. In Bundibugyo, where 59 cases
with intestinal perforation were reported from January 1 to
December 31, 2011 and the intestinal perforation rate was 3%, we
estimate that there were 1,967 typhoid fever cases and an annual
incidence of 820 cases per 100,000 persons. Although based on a
different case definition and different case-finding method, these
incidences exceed rates observed in African urban slums of 247
per 100,000 [9], and indicate that intense, sustained typhoid
transmission occurs in rural areas of sub-Saharan Africa.
Males were disproportionately affected by intestinal perforation;
in Bundibugyo, and to a lesser extent in Kasese, this was more
pronounced among adults. In both districts, females with intestinal
perforation were younger than those without intestinal perfora-
tion, and the opposite was observed for male patients. The higher
frequency of intestinal perforation in males compared to females
has been well-documented in several case-series in Africa
[4,22,23], Asia [1,24], and the Caribbean [25], and male sex
was identified as a risk factor for intestinal perforation among
hospitalized typhoid patients in Turkey [3]. The reasons for this
often observed association remain unknown. We found fewer
published observations of the influence of age on the association
between intestinal perforation status and sex. A single study in
South Africa found that typhoid clinical features varied by sex
Figure 3. Cases of typhoid fever in Bundibugyo, by age, gender, and intestinal perforation status. January 1–December 31, 2011,
n = 244 with known age, sex, and intestinal perforation status, *P = 0.03 and **P = 0.0006.
doi:10.1371/journal.pntd.0002726.g003
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among adults but not children; however, in this study no cases of
intestinal perforation occurred among female patients of any age
[4]. The differences observed in our study may reflect age and
gender-specific care seeking behaviors or treatment adherence.
Alternatively, the relatively low rates of intestinal perforation
observed in women beyond the age of puberty may indicate that
sex hormones play a role in disease pathogenesis; in mouse models
of typhoid fever, estrogen decreased the intensity of infection [26].
Certain clinical factors, such as multiple health care visits and
taking two or more antibiotics, were associated with intestinal
perforation, suggesting that initial treatments were not effective.
Inadequate treatment of typhoid was previously described as a risk
factor for intestinal perforation among hospitalized typhoid
patients [3]. Chloramphenicol was the only antibiotic specifically
associated with intestinal perforation, and this may be related to
widespread chloramphenicol resistance among outbreak strains.
Loss of chloramphenicol susceptibility was previously associated
with a high rate of intestinal perforation during a typhoid fever
outbreak in Kinshasa, Democratic Republic of Congo, where
chloramphenicol was the drug of choice for empiric treatment of
typhoid [27]. Unlike in Kinshasa, expansion of chloramphenicol
resistance was not associated with a detectable increase in the
Table 2. Clinical features*of typhoid fever patients reported on case report forms, Kasese and Bundibugyo Districts, April 15,
2011–December 31, 2011.
No. (%) Kasese
Patients (n = 149{)
No. (%) Bundibugyo
Patients (n = 128{)
No. (%) All
Patients (n = 277{)
Clinical feature
Weakness 130 (87) 104 (81) 234 (84)
Headache 129 (87) 97 (76) 226 (82)
Joint Pain 106 (72) 88 (70) 194 (71)
Diarrhea 61 (41) 50 (39) 111 (40)
Not responding to antimalarials 51 (35) 42 (35) 93 (35)
Vomiting 52 (35) 39 (31) 91 (33)
Constipation 29 (20) 39 (31) 68 (25)
Intestinal Perforation 11 (8) 4 (3) 15 (6)
*Case definition specified that fever and abdominal pain must be present.
{For some items, n may vary by small numbers due to ‘‘don’t know’’ responses.
doi:10.1371/journal.pntd.0002726.t002
Table 3. Clinical history of typhoid fever patients, Kasese and Bundibugyo Districts, April 15, 2011–January 6, 2012.
Characteristic
No. (%) Kasese
Patients (n = 149{)
No. (%) Bundibugyo
Patients (n = 128{)
No. (%) All
Patients (n = 277{)
Previously sought care for this illness 105 (74) 83 (66) 188 (70)
Sought care from:* n = 105 n = 83 n = 188
Drug shop/Pharmacy 51 (49) 41 (49) 92 (49)
Health center/Hospital 50 (48) 40 (48) 90 (48)
Herbalist 7 (7) 6 (7) 13 (7)
Traditional healer 0 (0) 1 (1) 1 (1)
Other` 1 (1) 5 (6) 6 (3)
Took Antibiotics 60 (47) 51 (44) 111 (45)
Antibiotics taken:* n = 60 n = 51 n = 111
Metronidazole 21 (35) 19 (37) 40 (36)
Ciprofloxacin 14 (23) 16 (31) 30 (27)
Co-trimoxazole 17 (28) 12 (24) 29 (26)
Amoxicillin 15 (25) 12 (24) 27 (24)
Chloramphenicol 2 (3) 3 (6) 5 (5)
Other`` 7 (12) 4 (8) 11 (10)
$2 antibiotics 12 (20) 14 (27) 26 (23)
Took Antimalarials 74 (56) 83 (70) 157 (62)
{For some items, n may vary by small numbers due to ‘‘don’t know’’ responses.
*Percentage totals may be .100%; respondents could select $1 source of care and antibiotic.
`Kasese patients: 1 school nurse; Bundibugyo patients: 5 friend or relative.
``Kasese patients: 1 each cephalexin, erythromycin, gentamycin, 4 unknown; Bundibugyo patients: 1 each ceftriaxone and doxycycline, 2 unknown.
doi:10.1371/journal.pntd.0002726.t003
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intestinal perforation rate; this may be because chloramphenicol
use was rare among Uganda typhoid patients.
For the first time in this epidemic, MDR Salmonella Typhi
isolates predominated among the outbreak strains and an isolate
resistant to nalidixic acid and with reduced susceptibility to
ciprofloxacin was identified. Recently, there have been multiple
reports of widespread MDR Salmonella Typhi in East and Central
Africa. In the Democratic Republic of Congo, 30% of Salmonella
Typhi isolated from 2007–2011 were MDR, and 15% showed
nalidixic acid resistance and decreased susceptibility to ciproflox-
acin [14]; in an urban area in Kenya, 78% of Salmonella Typhi
isolates were MDR and 3% were resistant to nalidixic acid [9];
and in a 2009 outbreak in Malawi, all isolates were MDR and
10% were resistant to nalidixic acid [5]. Suboptimal dosage and
duration of therapy, as might occur with poor prescribing practices
and poor adherence to therapy, may accelerate the development
of antimicrobial resistance. We documented widespread improper
antibiotic use among Kasese and Bundibugyo patients; of those
who reported taking ciprofloxacin, only 18% completed the
recommended 14-day course and half took ciprofloxacin for 5 days
or fewer. Development of full ciprofloxacin resistance, alone or in
combination with MDR, would further limit treatment options in
western Uganda, as there are practical concerns about the use of the
three primary alternatives to ciprofloxacin there. The best orally
administered alternative to ciprofloxacin, azithromycin, is expensive
and not stocked by Ministry of Health-sponsored facilities; another
oral therapy, gatifloxacin, has been shown to be effective in areas
with widespread nalidixic acid resistance but has been pulled from
several markets due to severe side effects in adults and is not licensed
in Uganda; the third possibility, ceftriaxone, is stocked at Ugandan
hospitals and some health centers but must be administered
parenterally. In this resource-limited setting, emergence of cipro-
floxacin resistant Salmonella Typhi in the absence of alternative oral
therapies would be a devastating blow to the typhoid pharmacopeia,
and would likely result in increased rates of complications, including
intestinal perforation.
Piped drinking water was the probable primary transmission
vehicle in both districts. Although we did not isolate Salmonella
Typhi from water sources, the presence of E. coli, a marker of fecal
contamination, and the epidemiologic evidence are consistent with
a waterborne source of typhoid infection. Despite an ongoing
typhoid fever outbreak and recommendations to implement safe
water interventions, the percentage of patients who reported
treating water in the month before they became ill decreased from
22% in 2009 to 14% in 2011; in both districts the most common
reason for not treating water was the belief that treatment was not
necessary. This is consistent with the limited uptake of point-of-use
water treatment observed among at-risk populations in other parts
of the world [28,29]. Furthermore, uptake in Kasese in 2011 may
have been particularly low because the outbreak had passed the
acute emergency phase, in which supplies were provided free of
charge and treatment could be viewed as a temporary measure.




IP (n = 18*)
No. (%) Without
IP (n = 250*) P**
Clinical Characteristics
Previously sought care for this illness 17 (100) 166 (69) 0.004
Sought care from:{ n = 17 n = 166
Health center/Hospital 15 (88) 76 (46) 0.0008
Drug shop/Pharmacy 5 (29) 88 (48)
Herbalist 2 (12) 11 (7)
Took antibiotics 12 (75) 98 (44) 0.02
Antibiotics: n = 12 n = 98
Metronidazole 6 (50) 35 (36)
Co-trimoxazole 1 (8) 29 (30)
Ciprofloxacin 4 (33) 26 (27)
Amoxicillin 1 (8) 26 (27)
Chloramphenicol 3 (25) 1 (1) 0.004
Other` 3 (25) 9 (9)
$2 antibiotics 7 (58) 24 (24) 0.04
Took antimalarials 10 (67) 154 (62)
Reported not responding to antimalarials 10 (71) 76 (31) 0.003
Socioeconomic status
Owned $2 household items 10 (56) 201 (80) 0.02
Owned $2 animals 7 (39) 86 (34)
Percent unemployed 0 (0) 22 (9)
*For some items, n may vary by small numbers due to ‘‘don’t know’’ responses.
**Fisher’s Exact test.
{Percentage totals may be .100%; respondents could select $1 source of care and antibiotic.
`Patients with intestinal perforation: 1 each ceftriaxone, gentamycin, and unspecified; patients without intestinal perforation: 1 each cephalexin, doxycycline,
erythromycin, and gentamycin, and 5 unspecified.
doi:10.1371/journal.pntd.0002726.t004
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The enduring nature of this typhoid outbreak and emergence of
increasingly drug-resistant strains indicate a need for alternative
interventions. Providing treated water through the many piped
water systems that exist in both districts, and expanding these
systems to new areas would provide long-term reductions in risk of
typhoid and other waterborne diseases. Typhoid vaccination
should be strongly considered as a medium-term intervention that
controls the typhoid outbreak while water infrastructure improve-
ments are made.
These findings are subject to several limitations. The absence of
systematic typhoid surveillance before implementation of laborato-
ry-enhanced case-finding made it difficult to ascertain the true scope
of the outbreak. During enhanced case-finding, cases were missed,
both because the system did not capture patients who did not seek
care at government or private not-for-profit health facilities and
because some facilities chose not to participate in case-finding.
Missed cases may have differed from reported cases systematically
by sub-county of residence, socioeconomic status, clinical history,
and other factors. Typhoid fever is a diagnostic challenge,
particularly in malaria endemic areas where a large proportion of
fevers are attributed to malaria, and we attempted to balance the
sensitivity and specificity of the case definition with this in mind. We
included abdominal pain to increase specificity; however, by
improving specificity, we likely lost sensitivity to detect typhoid
patients early in the clinical course, before abdominal pain develops.
This may have impacted blood culture positivity, since positivity is
highest in the week following symptom onset [30]. The high number
of patients taking amoxicillin, ciprofloxacin, and co-trimoxazole
likely biased organisms recovered to those resistant to these
therapies. The imputation of missing data as negative responses
for clinical signs and symptoms and socioeconomic factors could
have biased results towards underestimation of frequencies. For
example, had missing data been censured, the calculated intestinal
perforation rates would have been higher, 12% and 5% in Kasese
and Bundibugyo, respectively. Additionally, due to the low positivity
of blood cultures, it is possible that many patients with non-
typhoidal febrile illness were included in the case definition, and the
true proportion with IP may have been higher. Accurate
identification of sub-counties of residence was challenged by missing
data, multiple spellings for the same location, and reorganization of
several western Kasese sub-counties in 2011.
Comprehensive, laboratory-enhanced surveillance for typhoid
fever is necessary in outbreak settings to characterize affected
populations, monitor disease trends, target interventions, and assess
their impact. Reliance on severe complications, such as intestinal
perforation, as surrogates for all cases can be misleading when
complication rates vary over time due to changes in treatment
practices or antimicrobial resistance. Given the many reports of
MDR and nalidixic acid resistant Salmonella Typhi in sub-Saharan
Africa, improving laboratory diagnostic capacity is crucial for making
appropriate, timely treatment recommendations. In areas of high
incidence where conventional approaches to safe water have not
stopped transmission and drug resistant strains are circulating, novel
approaches, such as typhoid vaccination, should be considered.
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